Voloridge Investment Management
VXRT

Voloridge Investment Management’s Vaxart VXRT Stock Holding History

Voloridge Investment Management’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-60,500
Closed -$535K – 1528
2020
Q2 		$535K Buy
+60,500
New +$174K 0.01% 1014

Other funds holding VXRT

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Voloridge Investment Management's VXRT Position: Q3 2020 in Review

Voloridge Investment Management sold out of Vaxart (VXRT) in Q3 2020, closing a stake of 60,500 shares — an estimated $535K sold.

Voloridge Investment Management first reported a position in VXRT in Q2 2020 and held it in 1 quarter. The position peaked at $535K in Q2 2020. 130 funds tracked by Wall St. Rank hold VXRT as of Q3 2020.

  • Voloridge Investment Management reported no remaining Vaxart position as of Q3 2020 after selling out during the quarter.
  • Voloridge Investment Management sold 60,500 Vaxart shares in Q3 2020, an estimated $535K.
  • Voloridge Investment Management first reported a position in Vaxart in Q2 2020 and held it in 1 quarter.
  • Voloridge Investment Management's Vaxart position peaked at $535K in Q2 2020.
  • 130 funds tracked by Wall St. Rank held Vaxart as of Q3 2020.

Based on Voloridge Investment Management's 13F filing for Q3 2020, filed 16 Nov 2020.